Last updated: April 26, 2026
PRED FORTE is the brand name for prednisolone acetate ophthalmic suspension (commonly known as Pred Forte). In the US market, supply is driven by branded-label manufacturing by the brand holder and, depending on geography and contracting, by authorized distributors and contract manufacturers under the brand holder’s quality systems.
Which companies supply PRED FORTE in the US?
Primary label supplier (brand manufacturing)
- Novartis Pharmaceuticals Corporation (US brand holder for “PRED FORTE”)
- The branded product is manufactured for label supply under the brand holder’s controlled supply chain.
Route to market
- Authorized distributors distribute PRED FORTE to wholesalers and pharmacies.
- Pharmacy chains often source via wholesalers that maintain availability of ophthalmic corticosteroids.
Who manufactures prednisolone acetate ophthalmic suspension used as PRED FORTE?
PRED FORTE is a prednisolone acetate 1% ophthalmic suspension product. The exact manufacturing site(s) used for the branded supply chain can vary by lot, but the regulatory responsibility sits with the US label holder and the approved manufacturing/packing facilities listed in product filings.
How do suppliers structure PRED FORTE availability?
Supply availability typically depends on four nodes:
- API and key excipients sourcing for ophthalmic suspension formulation
- Drug product manufacturing (fill-finish of sterile ophthalmic suspension)
- Packaging/labeling (bottle type, cap, and cartons)
- Wholesale distribution into retail and institutional channels
For branded ophthalmics, manufacturing and packaging are executed under FDA cGMP controls, with final product release performed by the manufacturer/label holder.
What do regulatory records show about the product’s supply chain?
US supply chain details for PRED FORTE (label holder, strength, dosage form, and approved manufacturing/packing) are documented in:
- FDA Orange Book listing for the referenced NDA/brand product
- FDA product label (package insert) for label holder and contact/manufacturer information
Supplier list (actionable market mapping)
| Supply role |
Typical supplier identity |
Evidence anchor |
| Brand holder / label responsibility |
Novartis Pharmaceuticals Corporation |
FDA label and Orange Book brand listing for PRED FORTE |
| Primary commercial distribution |
Wholesale distributors and authorized channels |
US distribution model for FDA-approved prescription products |
| Manufacturer / packer |
Approved manufacturing and packaging facilities tied to the NDA |
FDA approval records and product labeling/manufacturer blocks |
What about generic prednisolone acetate ophthalmic suspension?
If “PRED FORTE” is not available, pharmacies often substitute generic prednisolone acetate ophthalmic suspension 1% under the same therapeutic category (ophthalmic corticosteroid). Generic supply varies by contract manufacturer and current market throughput, but the active ingredient and strength remain the same as the branded product.
For procurement and forecasting, the practical approach is to treat branded “PRED FORTE” supply as label-holder driven and generic availability as dependent on the competitive set of FDA-approved generics in the Orange Book for prednisolone acetate ophthalmic suspension.
Key Takeaways
- PRED FORTE is a branded prednisolone acetate 1% ophthalmic suspension product.
- The US label responsibility sits with Novartis Pharmaceuticals Corporation (brand holder).
- Actual physical supply to pharmacies runs through approved manufacturing sites tied to the NDA plus wholesale distribution channels.
- When availability tightens, market substitution usually shifts from branded supply to Orange Book-approved generics of prednisolone acetate ophthalmic suspension 1%.
FAQs
1) Is PRED FORTE supplied by the same company that supplies the API?
Branded drug supply typically reflects a managed supply chain under the label holder’s quality system. API suppliers are not necessarily the same entity as the commercial drug product manufacturer and packer.
2) Who controls release of PRED FORTE lots?
Lot release is controlled within the approved manufacturing and label-holder system documented in FDA submissions and product labeling.
3) Are there approved generics to replace PRED FORTE?
Yes. Prednisolone acetate ophthalmic suspension 1% is available as generics, with multiple FDA-approved products listed in the Orange Book.
4) What determines whether PRED FORTE is in stock at wholesalers?
Manufacturing throughput, packaging/labeling capacity, lot release timing, and distributor ordering patterns drive availability.
5) Does “PRED FORTE” refer to the active ingredient or a specific product line?
It is a specific branded product line (prednisolone acetate ophthalmic suspension), not a generic therapeutic class.
References (APA)
[1] FDA. (n.d.). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/ob/
[2] FDA. (n.d.). Drug Label Information for PRED FORTE (prednisolone acetate ophthalmic suspension). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/
